News

Solid Biosciences Plans Engagement at Key Investor Events

Solid Biosciences Plans Engagement at Key Investor Events

Solid Biosciences to Participate in Notable Investor Conferences

Solid Biosciences Inc. (NASDAQ: SLDB), a pioneering firm in the field of genetic medicine, is excited to announce its engagement in several forthcoming investor conferences. This participation underscores its ongoing commitment to advancing innovative treatments for rare neuromuscular and cardiac diseases.

Upcoming Conferences

Jefferies Global Healthcare Conference

At the Jefferies Global Healthcare Conference, Solid Biosciences will have its President and CEO, Bo Cumbo, alongside Chief Medical Officer, Dr. Gabriel Brooks, lead a compelling fireside chat. This event is scheduled for a date in November, providing a platform for in-depth discussions about the company’s initiatives.

Piper Sandler Healthcare Conference

Following the Jefferies event, Mr. Cumbo and Dr. Brooks are also slated to participate in the Piper Sandler 37th Annual Healthcare Conference. Here, they will continue to share insights into Solid Biosciences’ strategic vision and advancements in gene therapy, scheduled for early December.

Live Webcast Access

Interested parties can view live webcasts of both the Jefferies and Piper Sandler fireside chats through the company’s Events page on its Investors section of the website. Archive replays will also be accessible for those wishing to catch up after the live events.

One-on-One Meetings

Institutional investors eager to engage directly with Solid Biosciences’ management during these conferences are encouraged to reach out to their respective Jefferies or Piper Sandler representatives to schedule one-on-one meetings.

About Solid Biosciences

Solid Biosciences is at the forefront of developing cutting-edge precision genetic medicines focused on rare neuromuscular and cardiac disorders. The company is advancing a robust pipeline that includes drug candidates like SGT-003 for Duchenne muscular dystrophy and SGT-212 for Friedreich's ataxia, among others. Solid’s broader aim is to integrate groundbreaking gene therapies that can transform patient care and improve the quality of life for those affected by these severe conditions.

Contact Information

Investor Relations:
Nicole Anderson
Director of Investor Relations and Corporate Communications
Solid Biosciences Inc.
Email: investors@solidbio.com

Media Inquiries:
Glenn Silver
FINN Partners
Email: glenn.silver@finnpartners.com

Frequently Asked Questions

What is the main focus of Solid Biosciences?

Solid Biosciences specializes in the development of precision genetic medicines for rare neuromuscular and cardiac diseases.

When are the upcoming investor conferences?

The investor conferences are scheduled in November and December, with specific dates announced for each event.

Who will represent Solid Biosciences at these conferences?

Bo Cumbo, President and CEO, and Dr. Gabriel Brooks, Chief Medical Officer, will represent the company.

How can investors access the live webcast?

Investors can access the live webcast through the Events page on the Solid Biosciences Investors section of their website.

What is the mission of Solid Biosciences?

Solid Biosciences aims to improve the daily lives of patients living with devastating rare diseases through innovative gene therapies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 268

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 234

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 84

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 193

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Updates for Edwards Lifesciences Corporation Investors

Updated Category News Views 157

Important Updates for Edwards Lifesciences Corporation Investors New York - Investors of Edwards Lifesciences Corporation (NYSE: EW) should remain aware of the recent developments concerning the securities class action lawsuit that affects their investments. This information is crucial for anyone who purchased securities of Edwards Lifesciences within the specified class...

Continue Reading
Investors Urged to Act: Zenas BioPharma Class Action Notice

Updated Category News Views 147

Investors Encouraged to Participate in Zenas BioPharma Class Action The Gross Law Firm has issued an important notice for shareholders of Zenas BioPharma, Inc. (NASDAQ: ZBIO), urging those who have incurred financial losses to seek options regarding a pending class action. This notice highlights the importance of taking timely steps for potential recovery. Understanding...

Continue Reading
Zinzino's Strategic Merger with It Works! Enhances Growth Potential

Updated Category News Views 1021

Zinzino and It Works! Merger: A Game-Changer in Health Sales Zinzino AB has officially announced a remarkable merger with the US-based direct sales company It Works!, a bold and strategic decision that is set to enhance the distribution capabilities of both companies across various markets. This merger, which combines unique strengths and resources, opens new avenues for...

Continue Reading
NEXE Innovations Expands Compostable Product Line in North America

Updated Category News Views 164

Exciting Developments at NEXE Innovations Based in Windsor, Ontario, NEXE Innovations Inc. is making significant strides in the compostable materials industry. Recently, the company announced a pivotal delivery of over 80,000 compostable coffee pods, available in three new product SKUs, to an esteemed office coffee services distributor in North America. Expanding Product...

Continue Reading
SubSplit Acquires Ideal Consolidated: Legacy Meets Future

Updated Category News Views 236

Market moves may come and go, but the real power play is knowing when a strategic acquisition is worth its weight in gold. SubSplit Services Group just pulled off one such move by nabbing Ideal Consolidated, Inc., a company that's been a fixture in South Bend, Indiana, since 1956. Yeah, that's a lot of history, folks, and SubSplit's decision to add that to their portfolio...

Continue Reading